
STRONGER TOGETHER: SWITZERLAND CHAMPIONS INTERNATIONAL PARTNERSHIPS AS KEY TO ACCELERATED INNOVATION, ONCE AGAIN SWITZERLAND IS SHOWCASING ITS BIOTECH EXCELLENCE AT BIO INTERNATIONAL IN BOSTON 16-19 JUNE, 2025
|
Global leader in scalable transcriptomics solutions for screening applications. |
|
Developing and supplying peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues (xPhoreTM platform). |
|
Acts as a life sciences cluster promoting networking and collaboration in the BioAlps community. |
|
Provides solutions in bioprocess engineering, ranging from development to production scale. |
|
Operates a life sciences campus that supports innovation and development in the healthcare and biotech sectors. |
|
Providing cutting-edge bioreactor technologies that simplify and automate cell-based therapies. |
|
Promotes Switzerland as a prime location for business and investment. |
|
Developing highly specific antibody therapeutics to target intracellular proteins presented on the major histocompatibility complex (MHC). |
|
Semiconductor manufacturer specialized in the design and production of ultra-low power, low voltage integrated circuits (IC) for battery-operated and field-powered applications. |
|
Utilizes cutting edge technology to analyze chiral molecules and biologics. |
|
Offers comprehensive property management services across Switzerland. |
|
Developing a patented oral topical therapy to cure and prevent oral mucositis and oral candidiasis. |
|
Develops and produces 3D microtissues for drug discovery and toxicity testing. |
|
Offers audit, tax, and advisory services to help organizations. |
|
They provide a unique platform technology that enable manufacturing of clinical-grade cell products at scale, through automation and standardization. |
|
Develops a new class of custom-built protein therapeutics known as DARPin® molecules. |
|
Revolutionizing the marking of cancer stem cells by offering a specific biomarker for several cancers, including lung, breast and colon |
|
Proven vaccine technology, focused on developing R&D assets and establishing partnerships to leverage the value of the technology to help protect health. |
|
Developing selective immunomodulators, which regulate T cell immune responses that play a key role in graft rejection and autoimmunity, while leaving the protective responses against infections and vaccination intact. |
|
Quality assurance consulting firm offering tailored solutions to the pharma industry aiming at enhancing compliance and improving processes in the execution of clinical trials. |
|
Engages in the research, development, and marketing of medicines in respiratory and vascular diseases. |
|
Focuses on developing precision drugs for the treatment of severe and rare diseases. |
|
Breaking new ground in the treatment of metabolic diseases |
|
Proprietary technology represents a significant advancement in antimicrobial therapies, setting a new standard in the industry. |
|
Provides high-tech laboratory services and research facilities for life sciences companies. |
|
Offers clinical trial management and pharmaceutical consulting services. |
|
Specializes in the assessment and valuation of growth companies in the life sciences and technology sectors. |
|
Dedicated to advancing mitochondrial transplantation therapy to treat acute and chronic degenerative diseases. |
|
Provides high-throughput screening services using innovative fluorescence-based technologies. |
|
Develops the first Organism-on-Chip technology for automated and ethical testing of drugs and chemicals. |
|
Specializes in microbiome analytics and solutions for healthcare and agricultural applications. |
|
Focuses on the development of breakthrough therapies for the treatment of central nervous system disorders. |
|
Offers digital solutions to enhance the efficiency and effectiveness of healthcare and medical management. |
|
Engages in the development of innovative oncology treatments. |
|
Provides infrastructure and support for startups and established companies in the life sciences sector. |
|
Specializes in virtual reality solutions, primarily for therapeutic and rehabilitation applications. |
|
Produces biopharmaceuticals using advanced cell line engineering and protein production technologies. |
|
Offers workshops and training in immunotherapy and biological production. |
|
Develops chitosan-based formulations to enhance the delivery of biopharmaceuticals. |
|
Specializes in developing therapies for respiratory diseases. |
|
Supports economic development in Valais, particularly in the sectors of technology, education, and innovation. |
|
Works on bioprocesses that utilize human stem cells for regenerative medicine. |
|
Provides laboratory services, R&D, and consulting to foster innovation in biotechnology. |
|
Offers services in drug development and manufacturing, with a focus on sustainable practices. |
|
Ymmunobio AG is a preclinical stage biotechnology company developing a novel class of immune oncology therapeutic antibodies. |
The SWISS BIOTECH companies will be available for media and partner interviews the entire week.
Media Contacts |
Partnerships & Business Development |
Lisette Müry |
Karine J. Wittmer |
E: [email protected] |
E. [email protected] |
|
|
Trade Fairs |
Foreign Direct Investment |
Export Promotion & Global Network |
Trade Commissioner |
Bettina Thomas |
Sean Powers |
E: [email protected] |
E: class="prnews_a" href="/cdn-cgi/l/email-protection#e8bb8d8986c5a5818b80898d84c6b8879f8d9a9ba88d8c89c4898c858186c68b80" rel="nofollow" Powers@eda,admi |
About Switzerland Global Enterprise
Switzerland Global Enterprise (S-GE) is the official Swiss organization for export and investment promotion with around 200 employees at locations throughout Switzerland and overseas. S-GE supports Swiss SMEs in their international business and helps innovative foreign companies to settle in Switzerland. In doing so, we rely on a unique network of national and international partners. This allows us to create added value for our customers and prosperity for Switzerland. As a non-profit organization, we provide a public service for our clients on behalf of the Swiss Confederation (State Secretariat for Economic Affairs SECO) and the cantons. We operate our 27 offices, the so-called Swiss Business Hubs, and Trade Points, in 31 countries jointly with the Federal Department of Foreign Affairs (FDFA). Thanks to our global network of partners, we also support our customers in many other countries.
SOURCE Swiss Business Hub USA

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- BTCC Exchange Appoints Dan Liu As CEO Ahead Of 14Th Anniversary Milestone
- Pharos Network Unveils High-Performance Layer 1 Testnet To Unlock RWA Adoption
- Primexbt Expands Global Reach With FSCA-Regulated Crypto Asset Services
- $ZEUS Marking His Territory: Announcing An IP Collaboration With Original Zeus Artist And Trademark Holder
- ALT5 Sigma Integrates Lightning Network With Voltage To Enable Instant Bitcoin Payments
- Bydfi And Ledger Launch Global Campaign With Limited Bydfi X Ledger Nano X
Comments
No comment